Pleomorphic medium-sized T-cell lymphoma following Hodgkin's disease (nodular sclerosis type)

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 4, 1997, Pages 411-416

  Gautier, Alain ^a   Teiltet, Françoise ^b   Davi, Frédéric ^c   Couturier, Jérôme ^d   Laye, Sylvain ^e   Raphael, M ^a  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^b HÔPITAL LOUIS MOURIER   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSTITUT CURIE   (France)

^e AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOGUAZONE; NAVELBINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINDESINE;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; PNEUMONIA; SPLENECTOMY; T CELL LYMPHOMA; VIRUS INFECTION;

ADULT; FEMALE; HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHOMA, T-CELL; LYMPHOMA, UNDIFFERENTIATED; NEOPLASMS, SECOND PRIMARY; SCLEROSIS;

EID: 0030899246     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Harris ML. The relationship between Hodgkin's disease and non Hodgkin's lymphoma. Semin Dlagn Pathol. 1992;9:304-310.
2. Bennett MH, Maclennan KA, Vaugham Hudson G, Vaugham Hudson B. Non Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. Ann Oncol. 1991;2(suppl 2):83-92.
3. Jaffe ES, Zarate-Osorno A, Medeiros LJ. The interrelationship of Hodgkin's disease and non Hodgkin's lymphomas: lesions learned from composite and sequential malignancies. Semin Diagn Pathol. 1992;9:297-303.
4. Dietrich PY, Henry-Amar M, Cosset JM, et al. Second primary cancers in patients continuously disease free from Hodgkin's disease: a protective role for the spleen? Blood. 1994;84:1209-1215.
5. Van Leeuwen FE, Klockman W), Hagenbeek A, et at. Second cancer risk following Hodgkin's disease. J Clin Oncol. 1994;12:312-32S.
6. Casey TT, Cousar JB, Mangum M, et al. Monomorphic lymphoma arising in patients with Hodgkin's disease. Am J Pathol. 1990;136:81-94.
7. Kingma DW, Medeiros LJ, Barletta J, et at. Epstein-Barr virus is infrequently identified in non Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol. 1994;18:48-61.
8. Tefferi A, Wiltsie JC, Kurtin PJ. Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease. Am J Hematol. 1992;40: 232-233.
9. Wlodarska I, Delabie J, De Wolf-Peeters C, et al. T-cell lymphoma developing in Hodgkin's disease: evidence for two clones. J Pathol. 1993;170:239-248.
10. Cowitt GT, Chan WC, Brynes RK, Heffner LT. T-cell lymphoma following Hodgkin's disease. Cancer. 1985;56:1191-1196.
11. Rysenga E, Linden MD, Carey JL, et al. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease. Arch Pathol Lab Med. 1995; 119:88-91.
12. Dick FR, Maca RD, Hankenson R. Hodgkin's disease terminating in a T cell immunoblastic leukemia. Cancer. 1978;42:1325-1329.
13. Boucheix C, Zittoun R, Reynes M, et at. Atypical T cell leukemia terminating in Hodgkin's disease. Cancer. 1979;44:1403-1407.
14. Armitage JD, Dick FR, Goeken JA, et at. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Arch Intern Med. 1983;143:445
15. Lowenthal RM, Harlow RWH, Mead AE, Tuck D, Challis DR. T-cell non Hodgkïn's lymphoma after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 1981 ;48:1586-1589.
16. Tosi P, Leoncini L, Del Vecchio MT, et al. Phenotypic overlaps between pleomorphic malignant T cell lymphomas and mixed cellularity Hodgkin's disease. IntJ Cancer. 1992;52:202-207.
17. Banks PM. The distinction of Hodgkin's disease from T cell lymphoma. Semin Diagn Palhol. 1992;9:279-283.
18. Smith LM, Evans JW, Mori M, Brown JM. The frequency of translocations after treatment for Hodgkin's disease. Intl Radial Oncol Biol Phys. 1992;24:737-742.
19. Vassallo J, Brousset P, Knecht H, et al. Detection of Epstein-Barr virus in Hodgkin's disease. Appl Immunohistochcm. 1993;1:213-219.
20. Masih A, Weisenburger D, Duggan M, et al. Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Ami Pathol. 1991;139:37-43.
21. Hansmann ML, Shibata D, Lorenzen J, et al. Incidence of Epstein-Barr virus bcl2 expression and translocation 1(14,18) in large cell lymphoma associated with paragranuloma (lymphocyte predominant Hodgkin's disease). Hum Pathol. 1994;25:240-243.
22. De Bruin PC, Jiwa M, Oudejans )), et al. Presence of Epstein-Barr in extranodal T-cell lymphomas: differences in relation to site. Blood. 1994;83:1612-1618.
23. Zhou XG, Hamilton Dutoit SJ, Van QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathohgy. 1994;24:115-122.
24. De Bruin PC, Jiwa NM, Van Der Valk P, et al. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T -cell lymphomas: relation between latent membrane protein-1 positivity and clinical course. Histopathology. 1993;23:509-518.
25. Bai MC, Jiwa NM, Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus positive Hodgkin's disease. J Palhol. 1994;174:49-55.
26. Tsang WY, Chan JK, Yip TT, et al. In situ localization of Epstein-Barr virus encoded RNA in non nasal/nasopharyngeal CD56 positive and CD56 negative T-cell lymphomas. Hum Palhol. 1994;25:758-765.
27. Korbjuhn P, Anagnostopoulos 1, Hummel M, et al. Frequent latent EpsteinBarr virus infection of neoplastic T-cells and bystander B cells in human immunodeficiency virus negative European peripheral pleomorphic T-cell lymphomas. Blood. 1993;82:217-223.